USPTO 2015–2025 USPTO PatentsView US Corporation

Moldex-Metric, Inc.

USPTO PatentsView assignee record - 37 granted patents across 17 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Moldex-metric ranks #8,644 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 17 technology areas.

#8,644
of 49,997 US assignees by volume
Top 9%
by Innovation Score (53.4/100)
10.5
avg claims per patent
+100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8644 · US Corporation #8,644 · 37 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 37 grants
  • UPPER-Q #8,644/49,997
  • PHOTO-FINISH Medallia
  • CPC-FOCUS A61F · 17 areas
  • INNOV-PAR 53.4/100
  • CLAIMS-PAR 10.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Medallia, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Moldex-metric’s 53.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Moldex-metric

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Moldex-metric's Innovation Score is 53.4/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Moldex-metric?

Each dot is one of Moldex-metric’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Moldex-metric’s own 10.5 claims/patent is at or below the 15.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Moldex-metric vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 36.937.037.03737.037.037.1 010203040 Granted patents (volume) Avg claims / patent Miura Co., Ltd. - 37, 8.32MiuraMedallia, Inc. - 37, 19.81MedalliaMidwest Industries, Inc. - 37, 5.16Midwest IndustriesMirati Therapeutics, Inc. - 37, 30.54Mirati Therapeuti…Montana State University - 37, 15.95Montana State Uni…Nakanishi Inc. - 37, 4.73NakanishiNetafim, Ltd. - 37, 22.51NetafimNexion S.P.A. - 37, 17.43Nexion S P AMoldex-Metric, Inc. - 37, 10.49Moldex-metric
Moldex-metric vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Moldex-metric's grants concentrate

Moldex-Metric, Inc. is a focused PatentsView assignee: 17 CPC subclasses with 35.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (10 grants) versus a trough of 1 in 2017. By volume, Moldex-metric sits between Miura Co., Ltd. and Nexion S.P.A..

Moldex-metric's three-year grant acceleration

Moldex-Metric, Inc. shows 16 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Moldex-Metric's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Moldex-Metric holds 37 patents at rank #8,643, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Moldex-Metric

By rank, the assignees closest to #8,643 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Moldex-Metric's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Moldex-Metric, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Moldex-Metric ranks #502 of 3,082 assignees by patent count in that subclass.

Moldex-metric's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 20152016201720182019202020212022202320242025 7
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Moldex-Metric, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 10.8%
2016 3 8.1%
2017 1 2.7%
2018 1 2.7%
2019 1 2.7%
2020 3 8.1%
2021 1 2.7%
2022 1 2.7%
2023 5 13.5%
2024 10 27.0%
2025partial year 7 18.9%

Which technologies does Moldex-Metric, Inc. patent most?

Top 15 of 17 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Moldex-Metric, Inc.'s patent record in context - here's where to go next.

  • Moldex-Metric, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 35.1% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #8,644 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Moldex-Metric, Inc. against Miura Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 53.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.